Are patients with stage III non-small cell lung cancer treated with chemoradiotherapy at risk for cardiac events? Results from a retrospective cohort study

OBJECTIVES: Dyspnoea is one of the symptoms frequently encountered after treatment with chemoradiotherapy (CRT) in stage III non-small cell lung cancer (NSCLC). Long-term data on mild to moderately severe cardiac events as underlying cause of dyspnoea in patients with stage III NSCLC are lacking. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Degens, Juliette, De Ruysscher, D, Houben, Ruud, Kietselaer, Bastiaan, Bootsma, Gerben, Hendriks, Lizza, Huijbers, Ellen, Schols, Annemie, Dingemans, Anne-Marie C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7523207/
https://www.ncbi.nlm.nih.gov/pubmed/32988942
http://dx.doi.org/10.1136/bmjopen-2019-036492

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7523207/
https://www.ncbi.nlm.nih.gov/pubmed/32988942
http://dx.doi.org/10.1136/bmjopen-2019-036492

Ejemplares similares